Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 171 - 180 of 198 Results.

What Are The Costs And Benefits of Patents for Prescription Drugs?
John R. Graham | Commentary | Jan. 25, 2012
Ask Not for Whom the Drug Tolls
Wendy McElroy | Commentary | Jan. 25, 2011
Life, Liberty And The Pursuit Of Fatty Foods
Trans fats may be bad for you, but government regulation is worse.
Art Carden | Commentary | Mar. 4, 2010
The Myth of Unregulated Tobacco
Bruce Yandle | Commentary | Sep. 10, 2009
How To Get a Liver When You Need One
Alexander T. Tabarrok | Commentary | June 30, 2009
State Legislators Must Join Supreme Court in Protecting Wine Consumers
Douglas Glen Whitman | Commentary | May 27, 2005
Bringing the Consumer Revolution to the FDA
Alexander T. Tabarrok | Commentary | Apr. 25, 2005
An Opportunity Or a Threat: How to Have Safer, Less Expensive Drugs
Paul H. Rubin | Commentary | Dec. 7, 2004
Vaccine Shortage Leads To The FDA’s Doorstep
Arthur E. Foulkes, Nicolas Heidorn | Commentary | Oct. 22, 2004
Only Distributors Reap Harvest of Wine Shipping Ban
Douglas Glen Whitman | Commentary | July 9, 2004






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL